1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends
  4. > Anti-Infective Drug News 09 FEBRUARY 2015

Anti-Infective Drug News 09 FEBRUARY 2015

  • February 2015
  • -
  • Espicom Business Intelligence
  • -
  • 20 pages

Industry Trend Analysis - Several Stakeholders To Benefit From Gilead's Expanded Deals With Indian Generics Companies
Industry Trend Analysis - Novartis Vaccine Business Picks Up Owing To Expanding Meningitis Market; Well-Timed For GSK
Industry Brief - Takeda Discontinues Phase II Programme For DTaP/sIPV Vaccine In Japan
Industry Brief - CHMP Issues Positive Opinion For Sivextro In ABSSSIs
Industry Brief - Pfizer Commits To Reduce Price For Prevenar 13 In World's Poorest Countries
Industry Brief - SII To Use Genticel's Vexiclase Platform To Develop Pertussis Vaccines
Industry Brief - FDA Accepts Actavis' sNDA For Teflaro Label Expansion
Industry Brief - CHMP Issues Positive Opinions For Kengrexal/Orbactiv/Raplixa
Industry Brief - First Patient Enrolled In New Drugs 4 Bad Bugs Programme
Industry Brief - AbbVie Reports Positive Results From Phase III Study Of All-Oral HCV Treatment In Japan
Industry Trend Analysis - FDA Turns Its Back On Merck For HCV; Repercussions For Achillion
Industry Brief - US Patent Protection For ContraVir's HBV Compound CMX157 Extended
Industry Brief - Study Compares Flublok To Traditional Egg-Based Flu Vaccine; Results Expected In Q215
Industry Brief - EnvisionRx/Gilead Team Up For HCV Treatments
Industry Trend Analysis - Chimerix' Discontinuation Of Brincidofovir Ebola Trials To Be Start Of A Trend
Industry Trend Analysis - Approval Of Evotaz Will Keep BMS In HIV Market But Gilead Will Prevail Once Again
Industry Brief - Enrolment/Dosing Begin In Abivax' ABX464 Phase IIa Trial For HIV
Industry Brief - FDA Approves Prezcobix For HIV-1
Industry Brief - Strides Signs TAF Agreement With Gilead
Industry Brief - CytoDyn's PRO 140 Monotherapy Shows Promise In Phase IIb HIV Study
Industry Brief - GSK Extends Price Freeze Commitment For Gavi-Eligible Countries
Industry Brief - Quest Proposes Senior Notes Offering
Industry Brief - Matinas Acquires Aquarius BioTechnologies
Industry Brief - GSK Receives EU Approval For Three-Part Transaction With Novartis

Table Of Contents

Anti-Infective Drug News 09 FEBRUARY 2015

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
2016 Immunodiagnostic Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Special Chemistry, Drug of Abuse, Endocrine Function, Immunoprotein, Therapeutic Drug Monitoring, and Tumor Marker Tests,  Opport

2016 Immunodiagnostic Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Special Chemistry, Drug of Abuse, Endocrine Function, Immunoprotein, Therapeutic Drug Monitoring, and Tumor Marker Tests, Opport

  • $ 47500
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-company survey from VPGMarketResearch.com contains 1,650 pages and 890 tables. The report provides a granular strategic analysis of over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein ...

2016 Tumor Markers in 32 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Test--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Emerging Technologies, Opportunities for Suppliers

2016 Tumor Markers in 32 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Test--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Emerging Technologies, Opportunities for Suppliers

  • $ 47400
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-country survey from VPGMarketResearch.com contains over 1,300 pages and 500 tables. The survey is designed to assist diagnostics industry executives, as well as companies planning to diversify ...

2016 Cancer Diagnostic Testing Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Tumor Marker--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Technology Trends

2016 Cancer Diagnostic Testing Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Tumor Marker--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Technology Trends

  • $ 47400
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-country survey from VPGMarketResearch.com contains over 1,300 pages and 500 tables. The survey is designed to assist diagnostics industry executives, as well as companies planning to diversify ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.